Tag: Prescription Drugs
1999 to Mid-2000s Saw Increase in Seniors Using Prescription Meds
Polypharmacy increased, peaking at 43.0 percent in 2017 to March 2020; hyperpolypharmacy increased during 1999-2000 to 2007-2008
Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
Second- or third-line treatment yields significantly greater efficacy than chemotherapy, including longer overall survival
ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy
Risk for kidney failure with replacement therapy lower with ACEi, ARB treatment among individuals with advanced CKD
Study Looks at Abortion Rates With No-Test Telehealth Screening, Meds Mailing
Similar rates of complete abortion seen for no-test screening and mailing of mifepristone when compared with in-person care
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy Outcomes
Similar serious adverse event rate, clinical benefit seen for patients with versus those without a waiver
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage
FDA Approves New Drug to Treat Alzheimer’s
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer
Improved progression-free survival seen for amivantamab-lazertinib versus osimertinib as first-line treatment
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
Higher percentages of men and adults aged 35 to 49 years received medications for opioid use disorder
